Skip to main content
Equibles

Michael Faerm

CFO

Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.

About Michael Faerm

The company reported in an 8-K filed February 19, 2026 that Michael Faerm was appointed Chief Financial Officer, effective March 9, 2026.

“On February 15, 2026, the Board of Directors of AtaiBeckley Inc. (the “Company”) appointed Michael Faerm as the Company’s Chief Financial Officer, effective as of the date Mr. Faerm commences employment with ATAI Life Sciences US, Inc. (“ATAI US”), which is expected to occur on March 9, 2026 (the “Appointment Date”).”
Company Form 8-K, filed February 19, 2026 · Read the filing

Summary generated from SEC filings and earnings-call records held by Equibles.

Affiliation history

Recorded current and former roles; source labels appear when available.

  • Organization not stated

    CFO

    Proxy statement

    Current

    Start not stated–present

Company network

Recorded roles and call appearances connecting this person to public companies.

Company

Current role

CFO

Recent activity

Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.